Quantum BioPharma (NASDAQ: QNTM) has signed an agreement with a global pharmaceutical contract research organization to prepare an Investigational N ...

Three months of supplements with ellagic acid — an antioxidant — significantly eased fatigue, depression, and anxiety in MS ...

Studies by a growing number of labs have identified neurological health benefits from exposing human volunteers or animal ...

demyelination in chemo brain, or deficits of neurogenesis in Down syndrome. But the authors also cautioned that the study had limits. Not only is the Ts65Dn model an imperfect reflection of human ...

We came across a bullish thesis on argenx SE (ARGX) on Substack by FluentInQuality. In this article, we will summarize the ...

demyelination in chemo brain, or deficits of neurogenesis in Down syndrome. But the authors also cautioned that the study had limits. Not only is the Ts65Dn model an imperfect reflection of human ...

demyelination in chemo brain, or deficits of neurogenesis in Down syndrome. But the authors also cautioned that the study had limits. Not only is the Ts65Dn model an imperfect reflection of human ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsChristine Chiou - Senior Vice President, ...

We recently published a list of 13 Most Profitable Growth Stocks to Buy Now. In this article, we are going to take a look at where argenx SE (NASDAQ:ARGX) stands against other most profitable growth ...

While its model historically involved spinning out ... Myasthenia Gravis (MG), and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), as well as other unnamed ones. It has completed Phase ...